[Effect of different groups of first line DMT on endothelial damage in multiple sclerosis].
| Autor: | Spirina NN; Yaroslavl State Medical University, Yaroslavl, Russia., Spirin NN; Yaroslavl State Medical University, Yaroslavl, Russia., Dubchenco EA; Federal Center of Brain and Neurotechnologies, Mocsow, Russia., Boyko AN; Federal Center of Brain and Neurotechnologies, Mocsow, Russia.; Pirogov Russian National Research University, Moscow, Russia. |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (7. Vyp. 2), pp. 83-88. |
| DOI: | 10.17116/jnevro202012007283 |
| Abstrakt: | Introduction: Vascular changes, including destabilization of the blood-brain barrier, are common pathological signs in multiple sclerosis (MS). There are prerequisites, which indicate the direct effects of disease modifying therapy (DMT) on the state of the vascular wall and reduce the damage to the endothelium in MS. Aim of This Study: Was to identify and evaluate the relationship of endothelial dysfunction in patients with multiple sclerosis with used DMT. Materials and Methods: The study included 85 patients with a reliable diagnosis of MS according to the McDonald criteria of 2010 (56 women, 29 men) aged from 17 to 62 years (average age 36.3±1.2 years). All patients underwent a comprehensive clinical and neurological examination, laboratory tests (blood serum analysis for the content of adhesion molecules sICAM-1, sPECAM-1, sE-selectin, sP-selectin, for the content of homocysteine and matrix metalloproteinase 9 (MMR-9) by ELISA; blood plasma analysis for Von Willebrand factor antigen (vWf) by ELISA). The results of the study indicate a decrease of endothelial damage in MS during interferon therapy. Its also allow the use of indicators such as von Willebrand factor antigen, sPECAM-1, sE-selectin levels as potential markers of the effectiveness of DMT. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|